𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease

✍ Scribed by Gisela Llebaria; Javier Pagonabarraga; Jaime Kulisevsky; Carmen García-Sánchez; Berta Pascual-Sedano; Alexandre Gironell; Mercè Martínez-Corral

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
97 KB
Volume
23
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The prevalence of dementia in Parkinson's disease (PD) is close to 30%, and its incidence is 4 to 6 times higher than in age‐matched general population. PD with dementia (PDD) is mainly characterized by a predominant and progressive frontal‐subcortical impairment. The Mattis Dementia Rating Scale (MDRS) is a commonly used screening test that sensitively measures the degree of frontal‐subcortical defects. Although the MDRS has been validated as a screening test of cognitive dysfunction in nondemented PD patients (PD‐ND), its utility for screening dementia in PD is unknown. In order to validate the MDRS for diagnosis of PDD it was prospectively administered to 92 PD patients (57 PD‐ND, 35 PDD) fulfilling UK‐PDSBB criteria. Dementia was diagnosed according to DSM‐IV‐TR and a Clinical Dementia Rating (CDR) scale score ≥1. Univariate, logistic regression, and ROC curve analysis were carried out to measure the discriminative power of MDRS in PDD. Regression analysis showed MDRS total scores to independently differentiate PD‐ND from PDD (P < 0.001). Age and education did not predict the presence of dementia. ROC curve analysis showed a cut‐off score of ≤123 on the MDRS total scores to yield high sensitivity (92.65%), specificity (91.4%), positive and negative predictive values (PPV 83.3%, NPV 96.4%). A brief version of the MDRS obtained by the addition of the memory, initiation/perseveration, and conceptualization subscores yielded similar discriminant properties. The MDRS has an excellent discriminant ability to diagnose dementia in PD and provides an objective measure to distinguish PD‐ND from PDD. © 2008 Movement Disorder Society

📜 SIMILAR VOLUMES

Screening for late life depression: cut-
Screening for late life depression: cut-off scores for the Geriatric Depression Scale and the Cornell Scale for Depression in Dementia among Japanese subjects
✍ Andrea S. Schreiner; Hiroshi Hayakawa; Tomoko Morimoto; Tatsuyuki Kakuma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## Background Proper screening of depression among older adults depends on accurate cut‐off scores. Recent articles have recommended the Geriatric Depression Scale (GDS) and the Cornell Scale for Depression in Dementia (CSDD) for this screening. However, there has been no investigation

Brief cognitive tests in the screening o
Brief cognitive tests in the screening of dementia in Parkinson's disease
✍ Javier Pagonabarraga; Jaime Kulisevsky 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 1 views

We read with interest the article by Dujardin et al., in which the investigators aimed to design a simple neuropsychological battery able to easily and accurately screen for dementia in Parkinson's disease (PDD) in routine clinical practice. 1 Brief cognitive tests have been developed in the field o

Assessing the validity of deriving clini
Assessing the validity of deriving clinical dementia rating (CDR) global scores from independently-obtained functional rating scale (FRS) scores in vascular dementia with and without Alzheimer's disease
✍ Krista L. Lanctôt; Ging-Yuek R. Hsiung; Howard H. Feldman; Shababa T. Masoud; La 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views

however because of non-specific symptoms of some diseases in geriatric patients, no clear incidence was registered. In conclusion, in the present study, in nearly half of the off-label use of drugs, geriatric residents were not aware of this unapproved use. The off-label use of drugs was justified

Psychometric attributes of the rating sc
Psychometric attributes of the rating scale for gait evaluation in Parkinson's disease
✍ Marcos Serrano-Dueñas; Belén Calero; Soledad Serrano; Maite Serrano; Paulina Cor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## Abstract ## Background: The RSGE‐PD‐V2.0 is a specific measure for evaluation of gait impairment in PD. ## Objective: To check the RSGE‐PD‐V2.0 metrics attributes. ## Methods: In addition to demographic and historical data of PD, applied assessments were: Hoehn and Yahr staging (H&Y); impac

Metric properties of the mini-mental Par
Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease
✍ Marcos Serrano-Dueñas; Belén Calero; Soledad Serrano; Maite Serrano; Paulina Cor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

## Abstract Parkinson's disease (PD) is a chronic neurodegenerative disorder that causes cognitive impairment and dementia in ∼30% of patients. Objective: Compare metric qualities of Mini‐Mental Parkinson (MMP) and scales for outcomes in Parkinson's disease‐cognition (SCOPA‐COG) with respect to the